Month: <span>September 2024</span>

Home / 2024 / September
Clinical trial assesses the efficacy of suvorexant in reducing delirium in older adults
Post

Clinical trial assesses the efficacy of suvorexant in reducing delirium in older adults

August 29, 2024 by Juntendo University Research Promotion Center Delirium increases the risks of falls and dementia among older adults and the burden on healthcare providers. Researchers assess whether the sleep-promoting medication suvorexant could reduce delirium in older adults since insomnia is a major risk factor for delirium. Credit: Professor Kotaro Hatta from Juntendo University...

Post

Gene therapy gets a turbo boost from researchers

August 29, 2024 by University of Hawaii at Manoa Graphical abstract. Credit: Nucleic Acids Research (2024). DOI: 10.1093/nar/gkae534For decades, scientists have dreamed of a future where genetic diseases, such as the blood clotting disorder hemophilia, could be a thing of the past. Gene therapy, the idea of fixing faulty genes with healthy ones, has held...

New pancreatic cancer treatment proves effective in shrinking, clearing tumors
Post

New pancreatic cancer treatment proves effective in shrinking, clearing tumors

August 28, 2024 by University of Massachusetts Amherst Researchers at the University of Massachusetts Amherst and UMass Chan Medical School have demonstrated in mice a new method to combat pancreatic cancer. The study, published in Science Translational Medicine, outlines the synergistic effects of a novel nanoparticle drug-delivery system to activate an immune pathway in combination...

Zapping Hunger: The Next Big Thing in Weight Loss?
Post

Zapping Hunger: The Next Big Thing in Weight Loss?

By National Research Council of Science & TechnologyAugust 24, 2024 Dr. Ki-young Shin’s team at KERI is advancing research on neuromodulation technology, specifically transcranial random noise stimulation (tRNS), to treat metabolic syndrome by suppressing appetite through non-invasive electrical stimulation. Their clinical trials have shown promising results in reducing appetite and emotional eating, with further phases...

Guitar-string-inspired tech makes for better blood pressure monitoring
Post

Guitar-string-inspired tech makes for better blood pressure monitoring

By Ben CoxworthAugust 27, 2024 Blood vessels such as the carotid artery resonate in a distinct manner when excited by ultrasound pulses Depositphotos Currently, when doctors wish to continuously monitor a patient’s blood pressure, they surgically insert a catheter into one of the individual’s arteries. There could soon be a safer, much less invasive alternative,...

Ultrasound device shows promise for treating chronic pain
Post

Ultrasound device shows promise for treating chronic pain

by University of Utah The Diadem device invented by University of Utah researchers to treat chronic pain and depression. Credit: University of UtahPain is a necessary biological signal, but a variety of conditions can cause those signals to go awry. For people with chronic pain, the root is often faulty signals emerging deep within the...

Post

Epigenetics blood markers can help understand dementia risk

News Release 28-Aug-2024 Two linked papers from the University of Exeter and Maastricht University have together progressed research to show the potential for DNA methylation, an epigenetic marker, in understanding how genetics and lifestyle factors influence dementia risk. Peer-Reviewed PublicationUniversity of Exeter New research suggests that epigenetic markers in the blood could be useful for...

Post

New diabetes research in Scientific Reports links blood glucose levels and voice biomed tech

News Release 28-Aug-2024 Klick Labs’ latest findings highlight potential for voice-based blood sugar monitoring; discovery follows scientists’ pioneering work using vocal biomarkers and AI to detect Type 2 diabetes Peer-Reviewed PublicationKlick Applied Sciences NEW YORK/TORONTO – August 28, 2024 – As part of its ongoing exploration of vocal biomarkers and the role they can play...

miR-10b Inhibition: A strategy for treating metastatic breast cancer
Post

miR-10b Inhibition: A strategy for treating metastatic breast cancer

News Release 28-Aug-2024 “We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.” Peer-Reviewed PublicationImpact Journals LLC image: Figure 5: miR-10b inhibition by MN-anti-miR10b decreases Aldefluor accumulation and impairs spheroid formation. (A) Fluorescence microscopy of representative MDA-MB-231 cells after incubation with Aldefluor reagent. (B) Fluorescence microscopy of representative MCF-7 cells...